Back to Results
First PageMeta Content
Information / Erythropoiesis-stimulating agents / Pharmacology / Amgen / Metadata / Pharmacovigilance / Epoetin alfa / Erythropoietin / Identifier / Medicine / Growth factors / Data


Considerations on WHO’s BQ Proposal Joerg Windisch, PhD, Chair European Biosimilars Group (EBG) Chief Science Officer, Sandoz Biopharmaceuticals 60th INN Consultation WHO, Geneva, April 13th, 2015
Add to Reading List

Document Date: 2015-04-13 04:15:44


Open Document

File Size: 820,04 KB

Share Result on Facebook
UPDATE